Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Head and Neck Cancer

  Free Subscription

Articles published in Am J Gastroenterol

Retrieve available abstracts of 54 articles:
HTML format

Single Articles

    July 2021
  1. WANG SM, Katki HA, Graubard BI, Kahle LL, et al
    Population Attributable Risks of Subtypes of Esophageal and Gastric Cancers in the United States.
    Am J Gastroenterol. 2021 Jul 2. pii: 00000434-990000000-00035.
    PubMed     Abstract available

  2. KAMBOJ AK, Gibbens YY, Hagen CE, Wang KK, et al
    Esophageal Epidermoid Metaplasia: Clinical Characteristics and Risk of Esophageal Squamous Neoplasia.
    Am J Gastroenterol. 2021;116:1533-1536.
    PubMed     Abstract available

    June 2021
  3. ZHOU J, Li Z, Ji R, Wang P, et al
    Influence of Sedation on the Detection Rate of Early Cancer and Precancerous Lesions During Diagnostic Upper Gastrointestinal Endoscopies: A Multicenter Retrospective Study.
    Am J Gastroenterol. 2021;116:1230-1237.
    PubMed     Abstract available

    May 2021
  4. LAI RP
    Esophageal Squamous Cell Carcinoma: Time to Predict the Risk?
    Am J Gastroenterol. 2021 May 4. pii: 00000434-900000000-98794.

  5. RUMGAY H, Arnold M, Laversanne M, Whiteman DC, et al
    International Trends in Esophageal Squamous Cell Carcinoma and Adenocarcinoma Incidence.
    Am J Gastroenterol. 2021;116:1072-1076.
    PubMed     Abstract available

  6. RUBENSTEIN JH, Raghunathan T, Doan C, Schneider J, et al
    Validation of Tools for Predicting Incident Adenocarcinoma of the Esophagus or Esophagogastric Junction.
    Am J Gastroenterol. 2021;116:949-957.
    PubMed     Abstract available

    April 2021
  7. WANG QL, Ness-Jensen E, Santoni G, Xie SH, et al
    Development and Validation of a Risk Prediction Model for Esophageal Squamous Cell Carcinoma Using Cohort Studies.
    Am J Gastroenterol. 2021;116:683-691.
    PubMed     Abstract available

  8. HAN S, Kolb JM, Hosokawa P, Friedman C, et al
    The Volume-Outcome Effect Calls for Centralization of Care in Esophageal Adenocarcinoma: Results From a Large National Cancer Registry.
    Am J Gastroenterol. 2021;116:811-815.
    PubMed     Abstract available

  9. LONG Y, Lv X, Tang L, Yang J, et al
    A Tubulovillous Adenoma With High-Grade Intraepithelial Neoplasia in Upper Barrett's Esophagus.
    Am J Gastroenterol. 2021;116:628.

    March 2021
  10. MCMENAMIN UC, Liu P, Kunzmann AT, Cook MB, et al
    Circulating Sex Hormones Are Associated With Gastric and Colorectal Cancers but Not Esophageal Adenocarcinoma in the UK Biobank.
    Am J Gastroenterol. 2021;116:522-529.
    PubMed     Abstract available

    February 2021
  11. ZAGARI RM, Marasco G, Tassi V, Ferretti S, et al
    Risk of Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus in Patients With Achalasia: A Long-Term Prospective Cohort Study in Italy.
    Am J Gastroenterol. 2021;116:289-295.
    PubMed     Abstract available

  12. SHEN XC, Zhou YB, Zhu YJ, Chen DF, et al
    A Large Cavernous Hemangioma of Esophagus.
    Am J Gastroenterol. 2021;116:236.

    January 2021
  13. SAWAS T, Dilmaghani S, Dhaliwal L, Wang KK, et al
    Risk Factor Profiles Can Distinguish Esophageal Adenocarcinoma From Barrett's Esophagus.
    Am J Gastroenterol. 2021;116:198-201.
    PubMed     Abstract available

    December 2020
  14. WANG QL, Ness-Jensen E, Santoni G, Xie SH, et al
    Development and Validation of a Risk Prediction Model for Esophageal Squamous Cell Carcinoma Using Cohort Studies.
    Am J Gastroenterol. 2020 Dec 18. doi: 10.14309/ajg.0000000000001094.
    PubMed     Abstract available

  15. KATONA BW, Powers J, McKenna DB, Long JM, et al
    Upper Gastrointestinal Cancer Risk and Surveillance Outcomes in Li-Fraumeni Syndrome.
    Am J Gastroenterol. 2020;115:2095-2097.
    PubMed     Abstract available

    November 2020
  16. CANTO MI, Trindade AJ, Abrams J, Rosenblum M, et al
    Multifocal Cryoballoon Ablation for Eradication of Barrett's Esophagus-Related Neoplasia: A Prospective Multicenter Clinical Trial.
    Am J Gastroenterol. 2020;115:1879-1890.
    PubMed     Abstract available

  17. WANI S, Williams JL, Falk GW, Komanduri S, et al
    An Analysis of the GIQuIC Nationwide Quality Registry Reveals Unnecessary Surveillance Endoscopies in Patients With Normal and Irregular Z-Lines.
    Am J Gastroenterol. 2020;115:1869-1878.
    PubMed     Abstract available

    October 2020
  18. TRINDADE AJ, Rishi A
    Delay in Diagnosis of Barrett's Esophagus Cancer During the COVID-19 Pandemic: Lessons Learned.
    Am J Gastroenterol. 2020;115:1728-1730.

  19. KARHUS LL, Skaaby T, Petersen J, Madsen AL, et al
    Long-term Consequences of Undiagnosed Celiac Seropositivity.
    Am J Gastroenterol. 2020;115:1681-1688.
    PubMed     Abstract available

    August 2020
  20. LOPEZ-TOBARUELA JM, Valverde-Lopez F, Lopez de Hierro-Ruiz M, Redondo-Cerezo E, et al
    Hepatic Abscess After Biodegradable Esophageal Stent Placement: A Rare Complication.
    Am J Gastroenterol. 2020 Aug 19. doi: 10.14309/ajg.0000000000000821.

  21. IYER PG, Taylor WR, Johnson ML, Lansing RL, et al
    Accurate Nonendoscopic Detection of Barrett's Esophagus by Methylated DNA Markers: A Multisite Case Control Study.
    Am J Gastroenterol. 2020;115:1201-1209.
    PubMed     Abstract available

    July 2020
  22. WEI WQ, Hao CQ, Guan CT, Song GH, et al
    Esophageal Histological Precursor Lesions and Subsequent 8.5-Year Cancer Risk in a Population-Based Prospective Study in China.
    Am J Gastroenterol. 2020;115:1036-1044.
    PubMed     Abstract available

  23. COTTON CC, Shaheen NJ
    Overutilization of Endoscopic Surveillance in Barrett's Esophagus: The Perils of Too Much of a Good Thing.
    Am J Gastroenterol. 2020;115:1019-1021.
    PubMed     Abstract available

    June 2020
  24. QIN Y, Iyer PG
    Predicting Progression in Barrett's Esophagus: Is the Holy Grail Within Reach?
    Am J Gastroenterol. 2020;115:841-842.
    PubMed     Abstract available

  25. DAVISON JM, Goldblum J, Grewal US, McGrath K, et al
    Independent Blinded Validation of a Tissue Systems Pathology Test to Predict Progression in Patients With Barrett's Esophagus.
    Am J Gastroenterol. 2020;115:843-852.
    PubMed     Abstract available

  26. KAHN A, Shaheen NJ, Iyer PG
    Approach to the Post-Ablation Barrett's Esophagus Patient.
    Am J Gastroenterol. 2020;115:823-831.
    PubMed     Abstract available

    May 2020
  27. HOOGENES N, Daams F, Britstra R, Nielsen K, et al
    Cutaneous Metastasis From a Laryngeal Carcinoma After Push Method Percutaneous Endoscopic Gastrostomy.
    Am J Gastroenterol. 2020 May 14. doi: 10.14309/ajg.0000000000000674.

  28. CHAI N, Wang S, Xiang J, Zhai Y, et al
    Challenging Use of Digestive Endoscopic Tunnel Technique to Treat Schwannoma Originating in the Trachea.
    Am J Gastroenterol. 2020;115:650.

  29. TANG J, Liu F
    Plexiform Fibromyxoma: A Rare Mesenchymal Tumor Found in the Esophagus.
    Am J Gastroenterol. 2020;115:648.

    April 2020
  30. RODRIGUES-PINTO E, Macedo G, Baron TH
    Managing Those Tough Malignant Esophagogastric Strictures.
    Am J Gastroenterol. 2020;115:487-491.

    February 2020
  31. XIE SH, Ness-Jensen E, Rabbani S, Langseth H, et al
    Circulating Sex Hormone Levels and Risk of Esophageal Adenocarcinoma in a Prospective Study in Men.
    Am J Gastroenterol. 2020;115:216-223.
    PubMed     Abstract available

    December 2019
  32. WANG QL, Santoni G, Ness-Jensen E, Lagergren J, et al
    Association Between Metformin Use and Risk of Esophageal Squamous Cell Carcinoma in a Population-Based Cohort Study.
    Am J Gastroenterol. 2019 Dec 9. doi: 10.14309/ajg.0000000000000478.
    PubMed     Abstract available

    May 2019
  33. CHAI N, Zou J, Linghu E, Chai M, et al
    Autologous Skin-Grafting Surgery to Prevent Esophageal Stenosis After Complete Circular Endoscopic Submucosal Tunnel Dissection for Superficial Esophageal Neoplasms.
    Am J Gastroenterol. 2019;114:822-825.
    PubMed     Abstract available

    April 2019
  34. KAMIMURA K, Shinagawa-Kobayashi Y, Mizuno K, Terai S, et al
    Esophageal Stenosis by Prostate Cancer Metastasis.
    Am J Gastroenterol. 2019;114:685-687.

    January 2019
  35. FALK GW
    2017 David Sun Lecture: Screening and Surveillance of Barrett's Esophagus: Where Are We Now and What Does the Future Hold?
    Am J Gastroenterol. 2019;114:64-70.
    PubMed     Abstract available

    November 2018
  36. TORRES HA, Economides MP, Angelidakis G, Hosry J, et al
    Sofosbuvir-Based Therapy in Hepatitis C Virus-infected Cancer Patients: A Prospective Observational Study.
    Am J Gastroenterol. 2018 Nov 8. pii: 10.1038/s41395-018-0383.
    PubMed     Abstract available

    October 2018
  37. WANG Z, Thrift AP
    Helicobacter pylori Infection and Gastroesophageal Reflux Disease-Barrett's Esophagus-Esophageal Adenocarcinoma Sequence: Reply From Authors.
    Am J Gastroenterol. 2018 Oct 17. pii: 10.1038/s41395-018-0356.

    September 2018
  38. ABIDALI H, Muna-Aguon P, Vela S, Nanda R, et al
    Palmoplantar Hyperkeratosis and Strong Family History of Esophageal Cancer: Tylosis or Not?
    Am J Gastroenterol. 2018 Sep 13. pii: 10.1038/s41395-018-0275.

  39. KOUNTOURAS J, Doulberis M, Polyzos SA, Zeglinas C, et al
    Helicobacter pylori Infection and Gastroesophageal Reflux Disease-Barrett's Esophagus-Esophageal Adenocarcinoma Sequence.
    Am J Gastroenterol. 2018 Sep 3. pii: 10.1038/s41395-018-0214.

    June 2018
  40. NGUYEN T, Khan A, Liu Y, El-Serag HB, et al
    The Association Between Statin Use After Diagnosis and Mortality Risk in Patients With Esophageal Cancer: A Retrospective Cohort Study of United States Veterans.
    Am J Gastroenterol. 2018 Jun 27. pii: 10.1038/s41395-018-0169.
    PubMed     Abstract available

  41. WANG Z, Shaheen NJ, Whiteman DC, Anderson LA, et al
    Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0070.
    PubMed     Abstract available

    November 2017
  42. RUBENSTEIN JH, Pohl H, Adams MA, Kerr E, et al
    Overuse of Repeat Upper Endoscopy in the Veterans Health Administration: A Retrospective Analysis.
    Am J Gastroenterol. 2017;112:1678-1685.
    PubMed     Abstract available

    October 2017
  43. ZHAO H, Xu W, Wang Z
    Sweet's Syndrome: An Unusual Extraintestinal Manifestation of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112:1493.

    August 2017
  44. TRAMONTANO AC, Sheehan DF, Yeh JM, Kong CY, et al
    The Impact of a Prior Diagnosis of Barrett's Esophagus on Esophageal Adenocarcinoma Survival.
    Am J Gastroenterol. 2017;112:1256-1264.
    PubMed     Abstract available

  45. ZAKKO L, Visrodia K, Wang KK, Iyer PG, et al
    Editorial: The Effect of Bias on Estimation of Improved Survival After Diagnosis of Barrett's Esophagus.
    Am J Gastroenterol. 2017;112:1265-1266.
    PubMed     Abstract available

    July 2017
  46. WANI S, Gaddam S
    Editorial: Best Practices in Surveillance of Barrett's Esophagus.
    Am J Gastroenterol. 2017;112:1056-1060.
    PubMed     Abstract available

  47. NGUYEN T, Thrift AP, Yu X, Duan Z, et al
    The Annual Risk of Esophageal Adenocarcinoma Does Not Decrease Over Time in Patients With Barrett's Esophagus.
    Am J Gastroenterol. 2017;112:1049-1055.
    PubMed     Abstract available

  48. SANAKA MR, Parikh MP, Thota PN, Gupta NM, et al
    Use of a Novel Submucosal Tunneling and Endoscopic Resection (STER) Technique for the Removal of an Esophageal Leiomyoma.
    Am J Gastroenterol. 2017;111:986.

    June 2017
  49. ARNOLD M, Laversanne M, Brown LM, Devesa SS, et al
    Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030.
    Am J Gastroenterol. 2017 Jun 6. doi: 10.1038/ajg.2017.
    PubMed     Abstract available

  50. QUMSEYA BJ, Wani S, Gendy S, Harnke B, et al
    Disease Progression in Barrett's Low-Grade Dysplasia With Radiofrequency Ablation Compared With Surveillance: Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2017;112:849-865.
    PubMed     Abstract available

  51. KRISHNAMOORTHI R, Lewis JT, Krishna M, Crews NJ, et al
    Predictors of Progression in Barrett's Esophagus with Low-Grade Dysplasia: Results from a Multicenter Prospective BE Registry.
    Am J Gastroenterol. 2017;112:867-873.
    PubMed     Abstract available

    April 2017
  52. KOMANDURI S, Kahrilas PJ, Krishnan K, McGorisk T, et al
    Recurrence of Barrett's Esophagus is Rare Following Endoscopic Eradication Therapy Coupled With Effective Reflux Control.
    Am J Gastroenterol. 2017;112:556-566.
    PubMed     Abstract available

    January 2017
  53. GUTHIKONDA A, Cotton CC, Madanick RD, Spacek MB, et al
    Clinical Outcomes Following Recurrence of Intestinal Metaplasia After Successful Treatment of Barrett's Esophagus With Radiofrequency Ablation.
    Am J Gastroenterol. 2017;112:87-94.
    PubMed     Abstract available

    October 2016
  54. FLOREANI A, Mangini C, Reig A, Franceschet I, et al
    Thyroid Dysfunction in Primary Biliary Cholangitis: A Comparative Study at Two European Centers.
    Am J Gastroenterol. 2016 Oct 25. doi: 10.1038/ajg.2016.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.